GeminIQ Website Logo

Viewing STAA free

Subscribe for full history, 90+ metrics, screener, watchlist...

STAAR SURGICAL CO

STAA

Companies in Ophthalmic Goods

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
13215317616717314416419322418312795
Short Term Investments
323417235086724221386197
Accounts Receivable Net Current
81506034407810594659511294
F I F O Inventory Amount
505553534843403939353125
Assets Current
312312321293326368397384366365347328
Long Term Investments
-------07121418
Property Plant And Equipment Net
727373747585827872676356
Finance Lease Right Of Use Asset
--0000000000
Operating Lease Right Of Use Asset
293031333137383535343532
Goodwill
222222222222
Deferred Income Tax Assets Net
1321241555595
Other Assets Noncurrent
1127241911496321
Assets
451452456438457510538513493489472441
Liabilities And Stockhold…
Liabilities
Accounts Payable Current
912912111715191714911
Finance Lease Liability Current
--0000000000
Operating Lease Liability Current
665544554444
Other Liabilities Current
334140374843393535413632
Liabilities Current
616962596870666663655754
Finance Lease Liability Noncurrent
---------000
Operating Lease Liability Noncurrent
313234353335353131313228
Deferred Income Tax Liabilities Net
--0000111111
Asset Retirement Obligations Noncurrent
000000000000
Deferred Rent Credit Noncurrent
000---------
Defined Benefit Pension Plan Liabilities Noncurren…
667767755533
Liabilities
991071031011071121091041001039387
Stockholders Equity
Common Stock Value
100000000000
Additional Paid In Capital Common Stock
508505496485477471467457448437436420
Treasury Stock Value
-6-6-6-4--------
Accumulated Other Comprehensive Income Loss Net Of…
-7-7-7-6-6-7-6-5-5-4-3-3
Retained Earnings Accumulated Deficit
-143-148-130-139-122-68-33-43-51-47-55-64
Stockholders Equity
352344354337350397428409393386379358
Liabilities And Stockholders Equity
451452456438457510538513493489472441
Debt Securities Available For Sale Amortized Cost …
323417235086---38--
Allowance For Doubtful Accounts Receivable Current
100000000000
Debt Securities Available For Sale Amortized Cost …
---------12--
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
606060606060606060606060
Common Stock Shares Issued
505050505049494949494948
Shares Outstanding
504950505049494949494948
Treasury Stock Common Shares
0000-0------

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20262.01%-5.48%----------
2025-8.38%-12.96%-1.23%1.71%-0.37%-2.34%5.11%-7.52%-24.20%-5.44%35.68%71.62%
2024-10.98%2.06%-14.11%-8.97%2.42%-16.40%-9.53%-15.84%-24.42%1.07%-0.47%15.12%
2023----20.21%-24.65%-20.23%-4.38%-9.54%-14.29%13.00%41.95%30.66%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
5.12
4.55
5.21
4.94
4.78
5.23
5.99
5.80
5.84
5.62
6.11
6.05
Quick Ratio
5.12
4.55
5.21
4.94
4.78
5.23
5.99
5.80
5.84
5.62
6.11
6.05
Working Capital
251.40M
243.04M
259.57M
233.56M
258.14M
297.63M
330.77M
317.65M
303.04M
300.23M
290.29M
273.81M
Leverage & Debt
Debt to Equity
0.28
0.31
0.29
0.30
0.31
0.28
0.26
0.25
0.25
0.27
0.25
0.24
Interest Coverage TTM
-6.37
-19.96
-19.07
-19.25
-11.78
-2.13
4.24
4.15
3.44
4.02
2.74
4.34
Debt Ratio
0.22
0.24
0.22
0.23
0.23
0.22
0.20
0.20
0.20
0.21
0.20
0.20
Efficiency & Turnover
Asset Turnover TTM
0.64
0.50
0.46
0.47
0.59
0.63
0.68
0.70
0.72
0.71
0.72
0.75
Days Sales Outstanding TTM
76.12
97.53
130.28
104.27
68.36
100.35
115.99
103.18
71.66
88.95
98.72
93.81
Receivables Turnover TTM
4.79
3.74
2.80
3.50
5.34
3.64
3.15
3.54
5.09
4.10
3.70
3.89
Per Share Metrics
Diluted EPS TTM
-0.41
-1.62
-1.91
-1.92
-1.44
-0.41
0.44
0.33
0.31
0.43
0.41
0.52
Free Cash Flow Per Share TTM
-1.10
-0.81
-0.80
-0.88
-0.64
-0.16
0.53
0.28
0.43
-0.07
-0.69
-0.01
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
76.89%
76.19%
73.87%
71.70%
74.00%
76.32%
78.73%
79.24%
78.51%
78.36%
77.92%
77.97%
Operating Profit Margin TTM
-9.07%
-38.30%
-41.97%
-48.83%
-24.26%
-4.02%
7.53%
7.90%
7.05%
8.71%
6.01%
8.52%
Net Profit Margin TTM
-7.24%
-33.60%
-41.79%
-42.45%
-25.46%
-6.44%
6.38%
4.99%
4.69%
6.62%
6.56%
8.43%
Growth Metrics
Net Revenue Growth (1Y)
4.03%
-23.72%
-32.42%
-32.59%
-14.44%
-2.64%
10.01%
8.83%
10.70%
13.37%
11.04%
16.92%
Net Income Growth (1Y)
-70.41%
298.10%
-542.54%
-673.47%
-564.64%
-194.66%
6.99%
-35.61%
-53.32%
-46.18%
-46.19%
-23.18%
EPS Growth (1Y)
-70.75%
294.54%
-538.67%
-668.92%
-560.52%
-193.50%
5.71%
-36.54%
-53.95%
-46.78%
-46.75%
-24.02%
Valuation Metrics
P/E TTM
-44.38
-14.23
-13.84
-8.72
-12.24
-59.05
83.93
140.79
122.38
70.94
95.96
98.66
P/B TTM
2.65
3.33
3.77
2.47
2.49
3.00
4.27
5.72
4.77
3.92
5.16
7.12
P/S TTM
3.21
4.78
5.78
3.70
3.12
3.80
5.36
7.03
5.74
4.70
6.30
8.32
Market Cap
933.28M
1.14B
1.33B
830.95M
869.93M
1.19B
1.83B
2.34B
1.87B
1.51B
1.95B
2.55B
Enterprise Value
801.42M
991.38M
1.16B
663.81M
696.82M
1.05B
1.66B
2.15B
1.65B
1.33B
1.83B
2.45B
Calculated Values
Free Cash Flow TTM
-54.99M
-40.05M
-39.54M
-43.74M
-31.35M
-7.67M
26.30M
13.55M
20.88M
-3.59M
-33.53M
-534.00K
Net Debt
-131.86M
-153.15M
-176.16M
-167.13M
-173.11M
-144.12M
-163.92M
-192.65M
-223.86M
-182.83M
-127.18M
-94.41M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-03-13Purchase
Owner: Broadwood, Capital Inc, B…
Title: -
Shares: 316,017
Price/Share: $18.62
Value: $5,884,236.54
Shares Owned: 16,123,842
Relationship: Director,TenPercentOwner
Ownership: Direct
2026-01-09Purchase
Owner: Bradsher, Neal C, Broadwo…
Title: -
Shares: 27,485
Price/Share: $22.05
Value: $606,044.25
Shares Owned: 15,453,629
Relationship: TenPercentOwner
Ownership: Direct
2026-01-08Purchase
Owner: Bradsher, Neal C, Broadwo…
Title: -
Shares: 3,240
Price/Share: $21.94
Value: $71,085.60
Shares Owned: 15,426,144
Relationship: TenPercentOwner
Ownership: Direct
2025-11-21Purchase
Owner: Bradsher, Neal C, Broadwo…
Title: -
Shares: 797,486
Price/Share: $27.86
Value: $22,217,959.96
Shares Owned: 15,019,491
Relationship: TenPercentOwner
Ownership: Direct
2025-04-10Purchase
Owner: Bradsher, Neal C, Broadwo…
Title: -
Shares: 900
Price/Share: $15.18
Value: $13,662.00
Shares Owned: 13,519,491
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
106.82%
Inst. Shares: 53,310,417
Shares Outstanding: 49,908,000
2025-12-31
104.87%
Inst. Shares: 51,979,591
Shares Outstanding: 49,568,000
2025-09-30
100.08%
Inst. Shares: 49,674,282
Shares Outstanding: 49,633,000
2025-06-30
107.98%
Inst. Shares: 53,470,062
Shares Outstanding: 49,520,000
2025-03-31
104.80%
Inst. Shares: 51,710,675
Shares Outstanding: 49,344,000

STAAR SURGICAL CO (STAA) — SEC Financial Statements & Analysis

STAAR SURGICAL CO (STAA) is a ophthalmic goods company, incorporated in DE. STAAR SURGICAL CO trades on Nasdaq as: STAA. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), STAAR SURGICAL CO reported a 4.03% year-over-year revenue growth, a Gross Profit Margin of 76.89% (TTM), a Debt-to-Equity ratio of 0.28x, a Price-to-Sales (P/S) ratio of 3.21x (TTM), a Price-to-Book (P/B) ratio of 2.65 (TTM), at a market cap of $933.28M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
4.03%
Gross Profit Margin TTM
76.89%
Debt To Equity
0.28x
P/S TTM
3.21x
P/B TTM
2.65
Market Cap
$933.28M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is STAAR SURGICAL CO in?

STAAR SURGICAL CO (STAA) operates in the Ophthalmic Goods industry.

What is STAA's market cap?

STAAR SURGICAL CO (STAA) has a market capitalization of $933.28M as of 2026-03-31.

What exchange does STAA trade on?

STAAR SURGICAL CO (STAA) trades on the Nasdaq.

Where is STAAR SURGICAL CO incorporated?

STAAR SURGICAL CO is incorporated in DE.

Research Faster.
Invest Smarter.

STAAR SURGICAL CO (STAA) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.